ConductScience.org, home

Paper17123761

Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.

Nakagawa T and 5 others. J Ethnopharmacol, 2007. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats. Papers, record 17123761. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17123761

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.
PubMed
Journal
J Ethnopharmacol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2019-12-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakagawa TTakako
2Goto HHirozo
3Hikiami HHiroaki
4Yokozawa TTakako
5Shibahara NNaotoshi
6Shimada YYutaka

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, ExperimentalMajor topic
Drugs, Chinese HerbalMajor topic
KidneyMajor topic
Oxidative StressMajor topic
8-Hydroxy-2'-Deoxyguanosine
Animals
Blood Glucose
Creatinine
Deoxyguanosine
Fibronectins
Hyperglycemia
Lipid Peroxidation
Male
Medicine, Traditional
Organ Size
Phytotherapy
Plant Preparations
Protective Agents
Proteinuria
Rats
Rats, Wistar
Transforming Growth Factor beta1
Weight Loss

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
35529925The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35529925PubMed
35004802A Review on the Mechanism and Application of Keishibukuryogan.Front Nutr2021https://conductscience.org/library/papers/35004802PubMed
30235697Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study.Medicine (Baltimore)2018https://conductscience.org/library/papers/30235697PubMed
28018473Evaluation of the In Vivo Therapeutic Effects of Radix Paeoniae Rubra Ethanol Extract with the Hypoglycemic Activities Measured from Multiple Cell-Based Assays.Evid Based Complement Alternat Med2016https://conductscience.org/library/papers/28018473PubMed
27549514Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.Sci Rep2016https://conductscience.org/library/papers/27549514PubMed
27342654Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.Int Urol Nephrol2016https://conductscience.org/library/papers/27342654PubMed
25793003Effect of keishibukuryogan on genetic and dietary obesity models.Evid Based Complement Alternat Med2015https://conductscience.org/library/papers/25793003PubMed
23529746Chinese medicine for treating diabetic nephropathy.Chin J Integr Med2011https://conductscience.org/library/papers/23529746PubMed
23044503The effects of medicinal plants on renal function and blood pressure in diabetes mellitus.Cardiovasc J Afr2012https://conductscience.org/library/papers/23044503PubMed
21253500The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells.Mediators Inflamm2010https://conductscience.org/library/papers/21253500PubMed
19633031Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.Evid Based Complement Alternat Med2011https://conductscience.org/library/papers/19633031PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17123761

GET https://conductscience.org/api/papers/v1/17123761/authors